MicroRNA-210 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3

Oncology Research

Volumn 21, Issue 3, 2013, Pages 145-154

  Wang, Zhengguang ^a   Yin, Bangliang ^a   Wang, Bing ^a   Ma, Zemin ^a   Liu, Weidong ^a   Lv, Guohua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ephrin A3 (EFNA3); Invasion; Malignant peripheral nerve sheath tumor (MPNST); MicroRNA (miR 210); Proliferation

Indexed keywords

EPHRIN A3; MICRORNA 210; MICRORNA; MIRN210 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NEUROFIBROMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; TUMOR CELL; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL GROWTH; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; METABOLISM; PATHOLOGY; TUMOR INVASION;

CELL GROWTH PROCESSES; DOWN-REGULATION; EPHRIN-A3; HEK293 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEUROFIBROMA; REAL-TIME POLYMERASE CHAIN REACTION; S PHASE; TRANSFECTION;

EID: 84905976549     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13841340689573     Document Type: Article

References (29)

1. Doorn, P. F.; Molenaar, W. M.; Buter, J.; Hoekstra, H. J. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur. J. Surg. Oncol. 21:78-82; 1995.
2. Jakobiec, F. A.; Font, R. L.; Zimmerman, L. E. Malignant peripheral nerve sheath tumors of the orbit: A clinicopathologic study of eight cases. Trans. Am. Ophthalmol. Soc. 83: 332-366; 1985.
3. Foley, K. M.; Woodruff, J. M.; Ellis, F. T.; Posner, J. B. Radiation-induced malignant and atypical peripheral nerve sheath tumors. Ann. Neurol. 7:311-318; 1980.
4. Dunn, G. P.; Spiliopoulos, K.; Plotkin, S. R.; Hornicek, F. J.; Harmon, D. C.; Delaney, T. F.; Williams, Z. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J. Neurosurg. 118:142-148; 2013.
5. L'Heureux-Lebeau, B.; Saliba, I. Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors. Oncol. Targets Ther. 6:459-470; 2013.
6. Li, Q.; Shen, K.; Zhao, Y.; He, X.; Ma, C.; Wang, L.; Wang, B.; Liu, J.; Ma, J. MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/beta-catenin signaling pathway. FEBS Lett. 587:1742-1748; 2013.
7. Chusorn, P.; Namwat, N.; Loilome, W.; Techasen, A.; Pairojkul, C.; Khuntikeo, N.; Dechakhamphu, A.; Talabnin, C.; Chan-On, W.; Ong, C. K.; Teh, B. T.; Yongvanit, P. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumour Biol. 34:1579-1588; 2013.
8. Chai, G.; Liu, N.; Ma, J.; Li, H.; Oblinger, J. L.; Prahalad, A. K.; Gong, M.; Chang, L. S.; Wallace, M.; Muir, D.; Guha, A.; Phipps, R. J.; Hock, J. M.; Yu, X. MicroRNA- 10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci. 101:1997-2004; 2010.
9. Gong, M.; Ma, J.; Li, M.; Zhou, M.; Hock, J. M.; Yu, X. MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neurol. Oncol. 14:1007- 1017; 2012.
10. Itani, S.; Kunisada, T.; Morimoto, Y.; Yoshida, A.; Sasaki, T.; Ito, S.; Ouchida, M.; Sugihara, S.; Shimizu, K.; Ozaki, T. MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). J. Cancer Res. Clin. Oncol. 138:1501-1509; 2012.
11. Presneau, N.; Eskandarpour, M.; Shemais, T.; Henderson, S.; Halai, D.; Tirabosco, R.; Flanagan, A. M. MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. Br. J. Cancer 108:964-972; 2013.
12. Qiu, S.; Lin, S.; Hu, D.; Feng, Y.; Tan, Y.; Peng, Y. Interactions of miR-323/miR-326/miR-329 and miR-130a/ miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J. Transl. Med. 11:10; 2013.
13. Redova, M.; Poprach, A.; Besse, A.; Iliev, R.; Nekvindova, J.; Lakomy, R.; Radova, L.; Svoboda, M.; Dolezel, J.; Vyzula, R.; Slaby, O. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol. 34:481-491; 2013.
14. Puissegur, M. P.; Mazure, N. M.; Bertero, T.; Pradelli, L.; Grosso, S.; Robbe-Sermesant, K.; Maurin, T.; Lebrigand, K.; Cardinaud, B.; Hofman, V.; Fourre, S.; Magnone, V.; Ricci, J. E.; Pouyssegur, J.; Gounon, P.; Hofman, P.; Barbry, P.; Mari, B. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ. 18:465-478; 2011.
15. Hong, L.; Yang, J.; Han, Y.; Lu, Q.; Cao, J.; Syed, L. High expression of miR-210 predicts poor survival in patients with breast cancer: A meta-analysis. Gene 507:135-138; 2012.
16. Rothe, F.; Ignatiadis, M.; Chaboteaux, C.; Haibe-Kains, B.; Kheddoumi, N.; Majjaj, S.; Badran, B.; Fayyad-Kazan, H.; Desmedt, C.; Harris, A. L.; Piccart, M.; Sotiriou, C. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 6:e20980; 2011.
17. Chan, S. Y.; Loscalzo, J. MicroRNA-210: A unique and pleiotropic hypoxamir. Cell Cycle 9:1072-1083; 2010.
18. Cui, H.; Grosso, S.; Schelter, F.; Mari, B.; Kruger, A. On the pro-metastatic stress response to cancer therapies: Evidence for a positive co-operation between TIMP-1, HIF-1alpha, and miR-210. Front. Pharmacol. 3:134; 2012.
19. Giannakakis, A.; Sandaltzopoulos, R.; Greshock, J.; Liang, S.; Huang, J.; Hasegawa, K.; Li, C.; O'Brien-Jenkins, A.; Katsaros, D.; Weber, B. L.; Simon, C.; Coukos, G.; Zhang, L. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7:255-264; 2008.
20. Arocho, A.; Chen, B.; Ladanyi, M.; Pan, Q. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn. Mol. Pathol. 15:56-61; 2006.
21. Kim, J. H.; Park, S. G.; Song, S. Y.; Kim, J. K.; Sung, J. H. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis. 4:e588; 2013.
22. Liu, Y.; Han, Y.; Zhang, H.; Nie, L.; Jiang, Z.; Fa, P.; Gui, Y.; Cai, Z. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. PLoS One 7:e52280; 2012.
23. Yang, W.; Sun, T.; Cao, J.; Liu, F.; Tian, Y.; Zhu, W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp. Cell Res. 318:944-954; 2012.
24. Chen, W. Y.; Liu, W. J.; Zhao, Y. P.; Zhou, L.; Zhang, T. P.; Chen, G.; Shu, H. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. Hepatobiliary Pancreat. Dis. Int. 11:319-324; 2012.
25. Zhang, Z.; Sun, H.; Dai, H.; Walsh, R. M.; Imakura, M.; Schelter, J.; Burchard, J.; Dai, X.; Chang, A. N.; Diaz, R. L.; Marszalek, J. R.; Bartz, S. R.; Carleton, M.; Cleary, M. A.; Linsley, P. S.; Grandori, C. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8:2756-2768; 2009.
26. Fasanaro, P.; D'Alessandra, Y.; Di Stefano, V.; Melchionna, R.; Romani, S.; Pompilio, G.; Capogrossi, M. C.; Martelli, F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283:15878-15883; 2008.
27. Kuijper, S.; Turner, C. J.; Adams, R. H. Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc. Med. 17:145-151; 2007.
28. Lungu, G. F.; Li, M. L.; Xie, X.; Wang, L. V.; Stoica, G. In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. Int. J. Oncol. 30: 45-54; 2007.
29. Nakada, C.; Tsukamoto, Y.; Matsuura, K.; Nguyen, T. L.; Hijiya, N.; Uchida, T.; Sato, F.; Mimata, H.; Seto, M.; Moriyama, M. Overexpression of miR-210, a downstream target of HIF1alpha, causes centrosome amplification in renal carcinoma cells. J. Pathol. 224:280-288; 2011.